Search Results

There are 2521 results for: content related to: HCV therapeutics

  1. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  2. You have free access to this content
    Poster Session 2: Hepatitis C: Approved Therapeutic Agents

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 659A–709A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27516

  3. You have free access to this content
    Poster Session 4: Hepatitis C: New Agents (Not Approved)

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 1128A–1161A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27533

  4. You have free access to this content
    Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 714A–807A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28228

  5. The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1

    Journal of Viral Hepatitis

    Volume 22, Issue 3, March 2015, Pages: 254–262, T. Oze, N. Hiramatsu, T. Yakushijin, R. Yamada, N. Harada, N. Morishita, M. Oshita, E. Mita, T. Ito, Y. Inui, M. Inada, S. Tamura, H. Yoshihara, Y. Imai, M. Kato, T. Miyagi, Y. Yoshida, T. Tatsumi, A. Kasahara, N. Hayashi and T. Takehara

    Version of Record online : 31 JUL 2014, DOI: 10.1111/jvh.12289

  6. Pharmacokinetics of bound and unbound telaprevir in cirrhotic patients with moderate and severe hepatic impairment

    The Journal of Clinical Pharmacology

    Volume 55, Issue 10, October 2015, Pages: 1147–1156, Sivi Ouwerkerk-Mahadevan, Atef Halabi, Blanka Cieslarová, Indra Aerts, James Witek, Rodica Van Solingen-Ristea and Donghan Luo

    Version of Record online : 7 JUL 2015, DOI: 10.1002/jcph.545

  7. Incidence of virological failure and emergence of resistance with twice-daily vs every 8-h administration of telaprevir in the OPTIMIZE study

    Journal of Viral Hepatitis

    Volume 21, Issue 12, December 2014, Pages: 835–842, I. Dierynck, A. Ghys, J. Witek, D. Luo, K. Janssen, B. Daems, G. Picchio, M. Buti and S. De Meyer

    Version of Record online : 17 NOV 2014, DOI: 10.1111/jvh.12347

  8. Fatigue-induced changes in tonic vibration response (TVR) in humans: Relationships between electromyographic and biochemical events

    Muscle & Nerve

    Volume 38, Issue 5, November 2008, Pages: 1481–1489, Christelle Brerro-Saby, Stéphane Delliaux, Jean Guillaume Steinberg and Yves Jammes

    Version of Record online : 24 SEP 2008, DOI: 10.1002/mus.21117

  9. You have free access to this content
    HCV Therapeutics: New Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 730A–760A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26858

  10. You have full text access to this OnlineOpen article
    Telaprevir impairs renal function and increases blood ribavirin concentration during telaprevir/pegylated interferon/ribavirin therapy for chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 21, Issue 5, May 2014, Pages: 341–347, Y. Karino, I. Ozeki, S. Hige, M. Kimura, T. Arakawa, T. Nakajima, Y. Kuwata, T. Sato, T. Ohmura and J. Toyota

    Version of Record online : 25 AUG 2013, DOI: 10.1111/jvh.12162

  11. Renal impairment during the treatment of telaprevir with peginterferon and ribavirin in patients with chronic hepatitis C

    Hepatology Research

    Volume 44, Issue 12, November 2014, Pages: 1165–1171, Kazuto Fukuda, Yasuharu Imai, Naoki Hiramatsu, Keiko Irishio, Takumi Igura, Yoshiyuki Sawai, Sachiyo Kogita, Yuki Makino, Rui Mizumoto, Yasushi Matsumoto, Masanori Nakahara, Sinichiro Zushi, Nobuyuki Kajiwara, Tsugiko Oze, Sumio Kawata, Norio Hayashi and Tetsuo Takehara

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12229

  12. You have free access to this content
    Development and validation of a “capture-fusion” model to study drug sensitivity of patient-derived hepatitis C

    Hepatology

    Volume 61, Issue 4, April 2015, Pages: 1192–1204, Morven E. Cunningham, Alia Javaid, Jenny Waters, Joseph Davidson-Wright, Joshua L.C. Wong, Meleri Jones and Graham R. Foster

    Version of Record online : 13 FEB 2015, DOI: 10.1002/hep.27570

  13. Effects of hypoxia on muscle response to tendon vibration in humans

    Muscle & Nerve

    Volume 34, Issue 6, December 2006, Pages: 754–761, Stéphane Delliaux and Yves Jammes

    Version of Record online : 29 AUG 2006, DOI: 10.1002/mus.20633

  14. Exploratory study on telaprevir given every 8 h at 500 mg or 750 mg with peginterferon-alpha-2b and ribavirin in hepatitis C patients

    Hepatology Research

    Volume 43, Issue 7, July 2013, Pages: 691–701, Fumitaka Suzuki, Yoshiyuki Suzuki, Hitomi Sezaki, Norio Akuta, Yuya Seko, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saito, Yasuji Arase, Kenji Ikeda, Rie Mineta, Sachiyo Watahiki, Mariko Kobayashi, Yoshiyuki Nakayasu, Hidetaka Tsuda, Keiji Aoki, Ichimaro Yamada and Hiromitsu Kumada

    Version of Record online : 29 NOV 2012, DOI: 10.1111/hepr.12009

  15. You have free access to this content
    HCV: Virology

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 926A–943A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26868

  16. Impact of Scheduled Angiographic Follow-Up in Patients Treated With Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

    Journal of Interventional Cardiology

    Volume 26, Issue 4, August 2013, Pages: 319–324, CATALIN MINDRESCU, SORIN J. BRENER, ALEJANDRA GUERCHICOFF, MARTIN FAHY, HELEN PARISE, ROXANA MEHRAN and GREGG W. STONE

    Version of Record online : 24 JUN 2013, DOI: 10.1111/joic.12038

  17. Botulinum toxin changes intrafusal feedback in dystonia: A study with the tonic vibration reflex

    Movement Disorders

    Volume 21, Issue 6, 6 June 2006, Pages: 777–782, Carlo Trompetto, Antonio Currà, Alessandro Buccolieri, Antonello Suppa, Giovanni Abbruzzese and Alfredo Berardelli

    Version of Record online : 6 FEB 2006, DOI: 10.1002/mds.20801

  18. You have free access to this content
    An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

    Hepatology

    Volume 54, Issue 4, October 2011, Pages: 1433–1444, Marc G. Ghany, David R. Nelson, Doris B. Strader, David L. Thomas and Leonard B. Seeff

    Version of Record online : 26 SEP 2011, DOI: 10.1002/hep.24641

  19. You have free access to this content
    Protease inhibitor-based triple therapy in chronic hepatitis C: guidelines by the French Association for the Study of the Liver

    Liver International

    Volume 32, Issue 10, November 2012, Pages: 1477–1492, Vincent Leroy, Lawrence Serfaty, Marc Bourlière, Jean-Pierre Bronowicki, Patrick Delasalle, Alexandre Pariente, Stanislas Pol, Fabien Zoulim and Georges-Philippe Pageaux

    Version of Record online : 14 AUG 2012, DOI: 10.1111/j.1478-3231.2012.02856.x

  20. You have free access to this content
    Telaprevir versus simeprevir for the treatment of recurrent hepatitis C after living donor liver transplantation

    Hepatology Research

    Volume 46, Issue 3, March 2016, Pages: E136–E145, Toru Ikegami, Tomoharu Yoshizumi, Yoshihro Yoshida, Takeshi Kurihara, Norifumi Harimoto, Shinji Itoh, Masahiro Shimokawa, Takasuke Fukuhara, Ken Shirabe and Yoshihiko Maehara

    Version of Record online : 6 JUL 2015, DOI: 10.1111/hepr.12546